Stephen Mahoney
2018 - Kiniksa Pharmaceuticals, Ltd.
In 2018, Stephen Mahoney earned a total compensation of $2.7M as President and Chief Operating Officer at Kiniksa Pharmaceuticals, Ltd., a 279% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $291,892 |
|---|---|
| Option Awards | $1,980,564 |
| Salary | $434,970 |
| Other | $11,000 |
| Total | $2,718,426 |
Mahoney received $2M in option awards, accounting for 73% of the total pay in 2018.
Mahoney also received $291.9K in non-equity incentive plan, $435K in salary and $11K in other compensation.
Rankings
In 2018, Stephen Mahoney's compensation ranked 4,307th out of 14,244 executives tracked by ExecPay. In other words, Mahoney earned more than 69.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,307 out of 14,244 | 70th |
Division Manufacturing | 1,597 out of 5,765 | 72nd |
Major group Chemicals And Allied Products | 571 out of 2,128 | 73rd |
Industry group Drugs | 478 out of 1,817 | 74th |
Industry Pharmaceutical Preparations | 371 out of 1,391 | 73rd |
Source: SEC filing on April 17, 2019.
Mahoney's colleagues
We found two more compensation records of executives who worked with Stephen Mahoney at Kiniksa Pharmaceuticals, Ltd. in 2018.
News
Signal Genetics CEO Scott Myers receives $36M in 2023
April 26, 2024
Dianthus Therapeutics Former President, Chief Financial and Operating Officer Stephen Mahoney's 2023 pay jumps 48% to $1.7M
April 11, 2024
Kiniksa Pharmaceuticals, Ltd. CEO Sanj Patel's 2019 pay falls 35% to $4.8M
April 28, 2020
Kiniksa Pharmaceuticals, Ltd. CEO Sanj Patel's 2018 pay jumps 389% to $7.3M
April 17, 2019